Figure 3 from Discovery and Validation of Molecular Biomarkers for Differentiation of Nondysplastic Barrett’s Esophagus from High-grade Dysplasia and Esophageal Adenocarcinoma

Read full text
Authors: Caroline L. Matchett, Seth W. Slettedahl, William R. Taylor, Calise K. Berger, Caryn E. Anderson, Melissa A. Passe, Ramona L. Lansing, Panwen Wang, Collin E. Chalmers, Patrick H. Foote, Jeanette E. Eckel‐Passow, Zhifu Sun
+11 more Douglas W. Mahoney, Don Chamil Codipilly, Cadman L. Leggett, Francisco C. Ramirez, Allon Kahn, Herbert C. Wolfsen, Swathi Eluri, Vani J. A. Konda, Arvind Julius Trindade, Prasad G. Iyer, John B. Kisiel
Cited by: 0

Abstract

Methylation and copy-number profiles in discovery and validation case and control sample sets. For methylation, each row is a marker from the filtered set of 52 MDMs and each column a patient sample. For copy number, each row is a chromosomal arm. Methylation marker levels measured in deciles above the 95th percentile value in NDBE are denoted by the increasing intensity of yellow to red color spectrum. Copy-number analysis shows amplifications (red) or deletions (blue) referent to neutral (white) as estimated by the AS method. NDBE referent to NE (gray, neutral by definition). EAC, esophageal adenocarcinoma.

Fields of Study & Subjects

Esophageal Cancer Research and Treatment Epigenetics and DNA Methylation Esophageal and GI Pathology

Publication details

Publication date
6 January 2026